Blocking RANKL inhibited osteosarcoma progression and lung metastasis in genetically engineered mouse models, and RANKL inhibitors even prevented osteosarcoma from occurring when utilized for pretreatment (Chen et al., 2015). This evidence concerns the gene TNFSF11 and osteosarcoma.